Successful treatment of esthesioneuroblastoma and neuroendocrine carcinoma with combined chemotherapy and proton radiation: Results in 9 cases

Archives of Otolaryngology - Head and Neck Surgery

Volumn 123, Issue 1, 1997, Pages 34-40

  Bhattacharyya, Neil ^a,c   Thornton, Allan F ^b   Joseph, Michael P ^a   Goodman, Max L ^a   Amrein, Philip C ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; ETOPOSIDE;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL PROTOCOL; FEMALE; HUMAN; INAPPROPRIATE VASOPRESSIN SECRETION; MALE; MENINGITIS; MUCOSA INFLAMMATION; NEURITIS; NEUROBLASTOMA; NEUROENDOCRINE TUMOR; PARANASAL SINUS CANCER; PROTON RADIATION; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0031030763     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.1997.01900010038005     Document Type: Article

References (27)

1. Morita A, Ebersold MJ, Olsen KD, Foote RL, Lewis JE, Quast LM. Esthesioneuroblastoma: prognosis and management. Neurosurgery. 1993;32:706-715.
2. Berger L, Luc R. L'esthesioneuroepitheliome olfactif. Bull Assoc Fr Etude Cancer. 1924;13:410-421.
3. Hyams VJ. Tumors of the upper respiratory tract and ear. In: Hyams VJ, Batsakis JS, Michaels L, eds. Atlas of Tumor Pathology. Washington, DC: Armed Forces Institute of Pathology; 1988;240-248. Second series, pt 25.
4. Kadish S, Goodman M, Wang CC. Olfactory neuroblastoma: a clinical analysis of 17 cases. Cancer. 1976;37:1571-1576.
5. Lund VJ, Milroy C. Olfactory neuroblastoma: clinical and pathological aspects. Rhinology. 1993;31:1-6.
6. Elkon D, Hightower SI, Lim ML, Cantrell RW, Constable WC. Esthesioneuroblastoma. Cancer. 1979;44:1087-1094.
7. Biller HF, Lawson W, Sachdev VP, Som P. Esthesioneuroblastoma: surgical treatment without radiation. Laryngoscope. 1990;100:1199-1201.
8. Levine PA, McClean WC, Cantrell RW. Esthesioneuroblastoma: the University of Virginia experience: 1960-1985. Laryngoscope. 1986;96:742-746.
9. Wade PM Jr, Smith RE, Johns ME. Response of esthesioneuroblastoma to chemotherapy: report of five cases and review of the literature. Cancer. 1984;53:1036-1041.
10. Newbill ET, Johns ME, Cantrell RW. Esthesioneuroblastoma: diagnosis and management. South Med J. 1985;78:275-282.
11. Kameya T, Shimosato Adachi I, Abe K, Ebihara S, Ono I. Neuroendocrine carcinoma of the paranasal sinuses: a morphological and endocrinologic study. Cancer. 1980;45:330-339.
12. Taxy JB, Bharani NK, Mills SE, Frierson HF Jr, Gould VE. The spectrum of olfactory neural tumors: a light-microscopic immunohistochemical and ultrastructural analysis. Am J Surg Pathol. 1986;10:687-695.
13. Silva EG, Butler JJ, Mackay B, Goepfert H. Neuroblastomas and neuroendocrine carcinomas of the nasal cavity: a proposed new classification. Cancer. 1982;50:2388-2405.
14. Foote RL, Morita A, Ebersold MJ, et al. Esthesioneuroblastoma: the role of adjuvant radiation therapy. Int J Radiat Oncol Biol Phys. 1993;27:835-842.
15. Dulguerov P, Calcaterra T. Esthesioneuroblastoma: the UCLA experience 1970-1990. Laryngoscope. 1992;102:843-849.
16. Cantrell RW. Esthesioneuroblastoma. In: Sekhar LN, Janecka IP, eds. Surgery of Cranial Base Tumors. New York, NY: Raven Press; 1993;471-476.
17. Nakissa N, Rubin P, Strohl R, Keys H. Ocular and orbital complications following radiation therapy of paranasal sinus malignancies and review of the literature. Cancer. 1983;51:980-986.
18. Sisson G, Toriumi D, Atiyah RA. Paranasal sinus malignancy: a comprehensive update. Laryngoscope. 1989;99:143-150.
19. Zappia JJ, Carroll WR, Wolf GT, Thornton AF, Ho L, Krause CJ. Olfactory neuroblastoma: the results of modern treatment approaches at the University of Michigan. Head Neck. 1993;15:190-196.
20. Spaulding CA, Kranyak MS, Constable WC, Stewart FM. Esthesioneuroblastoma: a comparison of two treatment eras. Int J Radiat Oncol Biol Phys. 1988;15:581-590.
21. Cheung NV, Heller G. Chemotherapy dose intensity correlates strongly with reponse, median survival and median progression-free survival in metastatic neuroblastoma. J Clin Oncol. 1991;9:1050-1058.
22. Polonowski JM, Brasnu D, Roux FX, Bassot V. Esthesioneuroblastoma: complete tumor response after induction chemotherapy. Ear Nose Throat J. 1990;69:743-746.
23. Weiden PL, Yarington CT Jr, Richardson RG. Olfactory neuroblastoma: chemotherapy and radiotherapy for extensive disease. Arch Otolaryngol. 1984;110:759-760.
24. O'Connor TA, McLean P, Juillard GJ, Parker RG. Olfactory neuroblastoma. Cancer. 1989;63:2426-2428.
25. Levine PA, Debo RF, Meredith SD, Jane JA, Constable WC, Cantrell RW. Craniofacial resection at the University of Virginia (1976-1992): survival analysis. Head Neck. 1994;16:574-577.
26. Richtsmeier WJ, Briggs RJ, Koch WM, et al. Complications and early outcome of anterior craniofacial resection. Arch Otolaryngol Head Neck Surg. 1992;118:913-917.
27. Levine PA, Stewart FM, Cantrell RW, Constable WC. Esthesioneuroblastoma: long-term outcome and patterns of failure the - University of Virginia experience. Cancer. 1994;73:2556-2562.